HUMAN HERPESVIRUS-6 INFECTION AND BONE-MARROW TRANSPLANTATION

被引：9

作者：

YOSHIKAWA, T

KOJIMA, S

ASANO, Y

机构：

[1] Department of Pediatrics, Fujita Health University School of Medicine, Toyoake

[2] Division of Hematology-Oncology, Children's Medical Center, Japanese Red Cross Nagoya First Hospital, Nagoya

来源：

LEUKEMIA & LYMPHOMA | 1992年 / 8卷 / 1-2期

关键词：

HERPESVIRUS-6; BMT; TRANSPLANTATION;

D O I：

10.3109/10428199209049819

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Human herpesvirus-6 (HHV-6) is ubiquitous in the human population and causes exanthem subitum, a benign disease seen in infancy. However it also produces a wide spectrum of clinical manifestations including cases with a fatal outcome. The virus remains latent in several organs, including the kidneys, liver, lymph/nodes and salivary glands, after the primary infection and reactivates when immune function is impaired. Reactivation of the virus occurred in a half of the bone marrow recipients 2 to 4 weeks after bone marrow transplantation (BMT). It remains to be established whether HHV-6 in fact causes the fever and rash observed in recipients who have reactivation of the virus. The data reviewed here will be required to compare with those of human herpesvirus 7 and a different group of HHV-6.

引用

页码：65 / 73

页数：9

共 70 条

[11]

Okuno T., Higashi K., Shiraki K., Yamanishi K., Takahashi M., Kondo Y., Ishibashi M., Takahara S., Sonoda T., Tanaka K., Baba K., Yabuuchi H., Kurata T., Human herpesvirus-6 infection in renal transplantation, Transplantation, 49, pp. 519-522, (1990)

[12]

Kikuta H., Itami N., Matsumoto S., Chikaraishi T., Togashi M., Frequent detection of human herpesvirus-6 DNA in peripheral blood mononuclear cells from kidney transplant patients, J. Infect. Dis., 163, (1991)

[13]

Yoshikawa T., Suga S., Asano Y., Nakashima T., Yazaki T., Ono Y., Fujita T., Tsuzuki K., Sugiyama S., Oshima S., Prospective study of human herpesvirus-6 infection in renal transplantation, Transplantation, (1992)

[14]

Ward K.N., Gray J.J., Efstathiou S., Brief report: primary human herpesvirus-6 infection in a patient following liver transplantation from a seropositive donor, J. Med. Virol., 28, pp. 69-72, (1989)

[15]

Asano Y., Yoshikawa T., Suga S., Nakashima T., Yazaki T., Fukuda M., Kojima S., Matsuyama T., Reactivation of herpesvirus type 6 in children receiving bone marrow transplants for leukemia, N. Engl. J. Med., 324, pp. 634-635, (1991)

[16]

Yoshikawa T., Suga S., Asano Y., Nakashima T., Yazaki T., Sobue R., Hirano M., Fukuda M., Kojima S., Matsuyama T., Human herpesvirus-6 infection in bone marrow transplantation, Blood, 78, pp. 1381-1384, (1991)

[17]

Asano Y., Yoshikawa T., Suga S., Yazaki T., Hata T., Nagai T., Kajita Y., Ozaki T., Yoshida S., Viremia and neutralizing antibody response in infants with exanthem subitum, J. Pediatr., 114, pp. 535-539, (1989)

[18]

Yoshiyama H., Suzuki E., Yoshida T., Kajii T., Yamamoto N., Role of human herpesvirus-6 infection in infants with exanthem subitum, Pediatr. Infect. Dis. J., 9, pp. 71-74, (1990)

[19]

Briggs M., Fox J., Tedder R.S., Age prevalence of antibody to human herpesvirus-6, Lancet, 1, pp. 1058-1059, (1988)

[20]

Brown N.A., Sumaya G.V., Liu G.R., Ench Y., Kovacs A., Coronesi M., Kaplan M.H., Fall in human herpesvirus-6 seropositivity with age, Lancet, 2, (1988)

← 1 2 3 4 5 6 7 →